BioSpace News Archive

NEOGEN Corporation (NASDAQ: NEOG) announced today that its genomics business located in Lincoln, Nebraska, has received a CLIA (Clinical Laboratory Improvement Amendments) Certificate of Compliance from the Center for Medicare & Medicaid Services (CMS).

Evofem Biosciences, Inc., announced that it has entered into a new agreement with VitaCare Prescription Services, a wholly-owned subsidiary of GoodRx, to provide enhanced “white glove” support services to women prescribed Phexxi® who choose to use VitaCare.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that Arpa Garay will join Moderna as Chief Commercial Officer, effective Monday, May 31, 2022.

Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2021 and provided a corporate update.

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting Dry Eye Disease (DED), announced today that it has successfully developed a rapid quantitative tear test for Lacritin, a tear protein that autonomously promotes tearing and is deficient in all forms of Dry Eye Disease.

LifeScan, a world leader in blood glucose monitoring, announced today the presentation of three studies showing the value of app-based technology in improving diabetes management.

Amgen (NASDAQ:AMGN) today announced top-line results from two Repatha® (evolocumab) open label extension (OLE) studies to the Phase 3 FOURIER cardiovascular outcomes trial.

IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of minimally-invasive cryoablation technology, the ProSense® System, that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it hosted three key ProSense® System events at the European Conference on Interventional Oncology (ECIO) from April 24 to 27, 2022 in Vienna, Austria.

Lexogen, a transcriptomics and Next-Generation Sequencing company today announced the release of the new CORALL RNA-Seq V2 whole transcriptome library prep kit.

Akerna (Nasdaq: KERN), a leading enterprise software company and developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry, today announces that management will report its financial results for the first quarter ended March 31, 2022, after the close of trading on Monday, May 9, 2022.